Back to Results
First PageMeta Content
Clinical pharmacology / Food and Drug Administration / Isotretinoin / Retinoids / IPLEDGE / Dermatologic and Ophthalmic Drugs Advisory Committee / Medical prescription / Pharmaceutical sciences / Pharmacology / Clinical research


Microsoft Word - iPLEDGE AM backgrounder FINAL.doc
Add to Reading List

Open Document

File Size: 352,30 KB

Share Result on Facebook

Company

Risk Management / Mylan / Risk / PharmD / /

Event

FDA Phase / /

IndustryTerm

reminder tools / healthcare delivery system / healthcare delivery / certain safety protocols / healthcare providers / generic products / /

MedicalCondition

premature birth / central nervous system malformations / severe recalcitrant nodular acne / spontaneous abortion / /

MedicalTreatment

counseling / contraceptive methods / /

Organization

Division of Risk Management office of Surveillance and Epidemiology / office of Medication Error Prevention / Dermatologic and Ophthalmic Drugs Advisory Committee / office of Planning / Food and Drug Administration / Planning and Policy Center for Drug Evaluation / Review Division / Ophthalmic Drugs Advisory Committee / FDAAA REMS / FDA / Division of Risk Management / Advisory Committee / /

Person

Claudia Karwoski / /

Position

Director / pharmacist / Director Memorandum / Chair / requesting pharmacist / Secretary / /

Product

Amnesteem / Claravis / Accutane / Sotret / H6 / ETASU / /

Technology

certain safety protocols / /

SocialTag